Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Justin Franklin Gainor, M.D.

Concepts (421)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Justin Gainor's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Justin Gainor has written about over time.
Receptor Protein-Tyrosine Kinases, 26 publications between 2011 and 2022, average publication date May 2016. Carbazoles, 7 publications between 2014 and 2021, average publication date May 2017. Pyridines, 26 publications between 2011 and 2024, average publication date February 2018. Piperidines, 11 publications between 2014 and 2024, average publication date April 2018. Pyrazoles, 33 publications between 2011 and 2024, average publication date May 2018. Drug Resistance, Neoplasm, 31 publications between 2013 and 2024, average publication date July 2018. Protein Kinase Inhibitors, 47 publications between 2011 and 2024, average publication date July 2018. Lactams, Macrocyclic, 13 publications between 2014 and 2022, average publication date January 2019. Lactams, 12 publications between 2015 and 2022, average publication date April 2019. Carcinoma, Non-Small-Cell Lung, 117 publications between 2011 and 2024, average publication date June 2019. Lung Neoplasms, 148 publications between 2011 and 2024, average publication date July 2019. Pyrimidines, 19 publications between 2014 and 2024, average publication date August 2019. Proto-Oncogene Proteins c-ret, 19 publications between 2013 and 2024, average publication date May 2020.

To see the data from this visualization as text, click here.
Gainor's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (421)
Explore
_
Co-Authors (219)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.